Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Ivermectin plus losartan as prophilaxy to severe events in patients with cancer with recent diagnosis of COVID-19
Epistemonikos ID: 67e24eb033785eea7a0fb13a9919e58c67315b11
First added on: Jun 26, 2020